Literature DB >> 2202729

Application of molecular cytogenetic techniques to the evaluation of renal parenchymal tumors.

G Kovacs1.   

Abstract

This guest editorial discusses the molecular cytogenetic features of human renal parenchymal tumors with an emphasis on their diagnostic usefulness. Important contributions of this review are discrimination (a) between papillary and nonpapillary renal cell carcinomas and (b) between tubulopapillary adenomas and papillary carcinomas. Speculations regarding the histogenesis of different renal parenchymal tumors are presented, with the hope that they may serve to diminish some of the confusion surrounding the classification of these tumors.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2202729     DOI： 10.1007/bf01612912

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  43 in total

1.  Morphological, autoradiographic, immunochemical and cytochemical investigation of a cell strain with trisomy 7 from a spontaneous abortus.

Authors:  A M Kuliev; V I Kukharenko; K N Grinberg; S S Vasileysky; V V Terskikh; L G Stepanova
Journal:  Humangenetik       Date:  1973

Review 2.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

3.  Further evidence that renal oncocytoma has malignant potential.

Authors:  K E Psihramis; P Dal Cin; S P Dretler; G R Prout; A A Sandberg
Journal:  J Urol       Date:  1988-03       Impact factor: 7.450

4.  Specific genetic change in tumors associated with von Hippel-Lindau disease.

Authors:  K Tory; H Brauch; M Linehan; D Barba; E Oldfield; M Filling-Katz; B Seizinger; Y Nakamura; R White; F F Marshall
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

5.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease.

Authors:  C R King; R N Schimke; T Arthur; B Davoren; D Collins
Journal:  Cancer Genet Cytogenet       Date:  1987-08

8.  Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma.

Authors:  P R Carroll; V V Murty; V Reuter; S Jhanwar; W R Fair; W F Whitmore; R S Chaganti
Journal:  Cancer Genet Cytogenet       Date:  1987-06

9.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

Authors:  P P Di Fiore; J H Pierce; M H Kraus; O Segatto; C R King; S A Aaronson
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

10.  Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas.

Authors:  G Kovacs; P Brusa; W De Riese
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396
View more
  3 in total

1.  Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p.

Authors:  H Brauch; S Pomer; T Hieronymus; T Schadt; H Löhrke; D Komitowski
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

2.  Interphase cytogenetics of multicentric renal cell tumours confirm associations of specific aberrations with defined cytomorphologies.

Authors:  B K Amo-Takyi; C Mittermayer; K Günther; S Handt
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

3.  High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.

Authors:  Maria V Yusenko; Roland P Kuiper; Tamas Boethe; Börje Ljungberg; Ad Geurts van Kessel; Gyula Kovacs
Journal:  BMC Cancer       Date:  2009-05-18       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.